KDKnut Dybwik

Knut Dybwik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Knut Dybwik has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A successful new method for single left lobe recruitment

    by Knut Dybwik, Erik W. Nielsen

    Key Clinical Message: Any gas will flow down the path of least resistance and highest compliance. This is a problem in the treatment of severe unilateral lung disease in the intensive care unit (ICU). Deep sedation interferes with the diaphragm's ability to distribute air into the lower lung. Spontaneous breathing in a conscious patient, in combination with mechanical ventilation via an endotracheal tube inserted into the left main stem bronchus, can recruit collapsed alveoli.

  • Open Access

    Gas embolism during surgery. A complement mediated condition?

    by Benjamin Stage Storm, Dorte Christiansen, Knut Dybwik, Tom Eirik Mollnes, Erik Waage Nielsen


  • Open Access

    Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis

    by Bernt C. Hellerud, Hilde L. Orrem, Knut Dybwik, Søren E. Pischke, Andreas Baratt-Due, Albert Castellheim, Hilde Fure, Grethe Bergseth, Dorte Christiansen, Miles A. Nunn, et al.

    Fulminant meningococcal sepsis, characterized by overwhelming innate immune activation, mostly affects young people and causes high mortality. This study aimed to investigate the effect of targeting two key molecules of innate immunity, complement component C5, and co-receptor CD14 in the Toll-like receptor system, on the inflammatory response in meningococcal sepsis. Meningococcal sepsis was simulated by continuous intravenous infusion of an escalating dose of heat-inactivated Neisseria meningitidis administered over 3 h. The piglets were randomized, blinded to the investigators, to a positive control group (n = 12) receiving saline and to an interventional group (n = 12) receiving a recombinant anti-CD14 monoclonal antibody together with the C5 inhibitor coversin. A substantial increase in plasma complement activation in the untreated group was completely abolished in the treatment group (p = 0.006). The following inflammatory mediators were substantially reduced in plasma in the treatment group: Interferon-γ by 75% (p = 0.0001), tumor necrosis factor by 50% (p = 0.01), Interleukin (IL)-8 by 50% (p = 0.03), IL-10 by 40% (p = 0.04), IL-12p40 by 50% (p = 0.03), and granulocyte CD11b (CR3) expression by 20% (p = 0.01). Inhibition of C5 and CD14 may be beneficial in attenuating the detrimental effects of complement activation and modulating the cytokine storm in patients with fulminant meningococcal sepsis.


  • Open Access

    Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis

    by Espen W. Skjeflo, Caroline Sagatun, Knut Dybwik, Sturla Aam, Sven H. Urving, Miles A. Nunn, Hilde Fure, Corinna Lau, Ole-Lars Brekke, Markus Huber-Lang, et al.

    Introduction: Sepsis is an exaggerated and dysfunctional immune response to infection. Activation of innate immunity recognition systems including complement and the Toll-like receptor family initiate this disproportionate inflammatory response. The aim of this study was to explore the effect of combined inhibition of the complement component C5 and the Toll-like receptor co-factor CD14 on survival, hemodynamic parameters and systemic inflammation including complement activation in a clinically relevant porcine model of polymicrobial sepsis. Methods: Norwegian landrace piglets (4 ± 0.5 kg) were blindly randomized to a treatment group (n = 12) receiving the C5 inhibitor coversin (OmCI) and anti-CD14 or to a positive control group (n = 12) receiving saline. Under anesthesia, sepsis was induced by a 2 cm cecal incision and the piglets were monitored in standard intensive care for 8 hours. Three sham piglets had a laparotomy without cecal incision or treatment. Complement activation was measured as sC5b-9 using enzyme immunoassay. Cytokines were measured with multiplex technology. Results: Combined C5 and CD14 inhibition significantly improved survival (p = 0.03). Nine piglets survived in the treatment group and four in the control group. The treatment group had significantly lower pulmonary artery pressure (p = 0.04) and ratio of pulmonary artery pressure to systemic artery pressure (p < 0.001). Plasma sC5b-9 levels were significantly lower in the treatment group (p < 0.001) and correlated significantly with mortality (p = 0.006). IL-8 and IL-10 were significantly (p < 0.05) lower in the treatment group. Conclusions: Combined inhibition of C5 and CD14 significantly improved survival, hemodynamic parameters and inflammation in a blinded, randomized trial of porcine polymicrobial sepsis.


  • Open Access

    Ethical challenges in home mechanical ventilation: A secondary analysis

    by Knut Dybwik, Erik Waage Nielsen, Berit Støre Brinchmann

    The aim of this study was to explore the ethical challenges in home mechanical ventilation based on a secondary analysis of qualitative empirical data. The data included perceptions of healthcare professionals in hospitals and community health services and family members of children and adults using home mechanical ventilation. The findings show that a number of ethical challenges, or dilemmas, arise at all levels in the course of treatment: deciding who should be offered home mechanical ventilation, respect for patient and family wishes, quality of life, dignity and equal access to home mechanical ventilation. Other challenges were the impacts home mechanical ventilation had on the patient, the family, the healthcare services and the allocation of resources. A better and broader understanding of these issues is crucial in order to improve the quality of care for both patient and family and assist healthcare professionals involved in home mechanical ventilation to make decisions for the good of the patient and his or her family.


  • Open Access

    "Fighting the system": Families caring for ventilator-dependent children and adults with complex health care needs at home

    by Knut Dybwik, Terje Tollåli, Erik W Nielsen, Berit S Brinchmann

    An increasing number of individuals with complex health care needs now receive life-long and life-prolonging ventilatory support at home. Family members often take on the role of primary caregivers. The aim of this study was to explore the experiences of families giving advanced care to family members dependent on home mechanical ventilation.


  • Open Access

    Home mechanical ventilation and specialised health care in the community: Between a rock and a hard place

    by Knut Dybwik, Erik W Nielsen, Berit S Brinchmann

    Home mechanical ventilation probably represents the most advanced and complicated type of medical treatment provisioned outside a hospital setting. The aim of this study was both to explore the challenges experienced by health care professionals in community health care services when caring for patients dependent on home mechanical ventilation, continual care and highly advanced technology, and their proposed solutions to these challenges.


  • Open Access

    Why does the provision of home mechanical ventilation vary so widely?

    by Knut Dybwik, Terje Tollåli, Erik Waage Nielsen, Berit Støre Brinchmann

    There is wide variation in the provision of home mechanical ventilation (HMV) throughout Europe, but the provision of home mechanical ventilation can also vary within countries. In 2008, the overall prevalence of HMV in Norway was 19.9/100,000, and there were huge regional differences in treatment prevalence. The aim of this study is to find explanations for these differences. We gathered multidisciplinary respondents involved in HMV treatment from five hospitals in five different counties to six focus group conversations to explore respondents’ views of their experiences systematically. We based the analysis on grounded theory. We found that uneven distribution of ‘‘enthusiasm’’ between hospitals seems to be an important factor in the geographical distribution of HMV. Furthermore, we found that the three subcategories, ‘‘high competence,’’ ‘‘spreading competence,’’ and ‘‘multidisciplinary collaboration,’’ are developed and used systematically in counties with ‘‘enthusiasm.’’ This culture is the main category, which might explain the differences, and is described as ‘‘wise enthusiasm.’’ The last subcategory is ‘‘individual attitudes’’ about HMV among decision-making physicians. The most important factor is most likely the uneven distribution of highly skilled enthusiasm between hospitals. Individual attitudes about HMV among the decision makers may also explain why the provision of HMV varies so widely. Data describing regional differences in the prevalence of HMV within countries is lacking. Further research is needed to identify these differences to ensure equality of provision of HMV.


    • 18 November 2004
      • Vol. 124  (22) , 2907-8

    [Drug interactions in an intensive care unit].

    by Erik Waage Nielsen, Knut Dybwik

    A new computerised interaction database in Norwegian is available at www.druid.uio.no and in some computer physician order entry systems. The scope of this paper was to assess drug use and examine the potential usefulness of DRUID in an intensive care unit. Drugs given patients during their first 24 hours in our mixed surgical intensive care unit over one year were entered into DRUID. 191 patients received 1413 drugs (median 7). According to DRUID, 110 patients (58%) had 274 potential drug interactions (median 2) of 72 classes. No interaction was of grade A (should not be combined) or C (absorption of oral drugs), 153 were of grade B (take precautions), and 121 were of grade D (academic interest). Of grade B interactions, 51% were in two and 49% in 39 classes of drug interactions. Of grade D interactions, 60% in 4 and 40% in 27 classes. Surprisingly few serious drug interactions were found. However, in every fourth patient precautions should be taken (e.g. dose adjustments). Electronic prescribing systems might give fewer adverse effects.